Physician Wealth Advisors’s Aemetis AMTX Stock Holding History

Physician Wealth Advisors’s Portfolio AMTX Stock Details AMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-498	Closed	-$867	–	1815
2025 Q1	$867	Buy	+498	New	+$1.06K	﹤0.01%	1184

Other funds holding AMTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Physician Wealth Advisors's AMTX Position: Q2 2025 in Review

Physician Wealth Advisors sold out of Aemetis (AMTX) in Q2 2025, closing a stake of 498 shares — an estimated $867 sold.

Physician Wealth Advisors first reported a position in AMTX in Q1 2025 and held it in 1 quarter. The position peaked at $867 in Q1 2025. 71 funds tracked by Wall St. Rank hold AMTX as of Q2 2025.

Physician Wealth Advisors reported no remaining Aemetis position as of Q2 2025 after selling out during the quarter.
Physician Wealth Advisors sold 498 Aemetis shares in Q2 2025, an estimated $867.
Physician Wealth Advisors first reported a position in Aemetis in Q1 2025 and held it in 1 quarter.
Physician Wealth Advisors's Aemetis position peaked at $867 in Q1 2025.
71 funds tracked by Wall St. Rank held Aemetis as of Q2 2025.

Based on Physician Wealth Advisors's 13F filing for Q2 2025, filed 14 Jul 2025.